Privia Health Group, Inc. (PRVA)
NASDAQ:PRVA
Want to see PRVA full AI Analyst Report?
PRVA Stock Chart & Stats
$24.02
$0.26(1.28%)
At close: 4:00 PM EST
$24.02
$0.26(1.28%)
Day’s Range― - ―
52-Week Range$18.77 - $26.51
Previous CloseN/A
Volume48.95K
Average Volume (3M)1.04M
Market Cap
$3.22B
Enterprise Value$2.54B
Total Cash (Recent Filing)$419.52M
Total Debt (Recent Filing)$9.02M
Price to Earnings (P/E)144.5
Beta0.73
Next Earnings
Aug 06, 2026EPS Estimate
0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.17
Shares Outstanding126,012,375
10 Day Avg. Volume1,150,981
30 Day Avg. Volume1,042,996
Financial Highlights & Ratios
PEG Ratio2.14
Price to Book (P/B)3.93
Price to Sales (P/S)1.36
P/FCF Ratio17.86
Enterprise Value/Market Cap0.79
Enterprise Value/Revenue1.13
Enterprise Value/Gross Profit11.79
Enterprise Value/Ebitda45.04
Forecast
1Y Price Target
$30.60Price Target Upside27.39% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
EPS Forecast (FY)0.24
Revenue Forecast (FY)$2.42B
Bulls Say, Bears Say
Bulls Say
Scale & Attributed LivesRapid provider and attributed‑lives growth materially increases Privia’s scale, improving negotiating leverage with payers, diversifying revenue across commercial/MA/Medicaid, and raising the addressable shared‑savings pool. Scale growth is a durable driver of recurring management fees and performance economics over multiple quarters.
Strong Balance Sheet & CashA cash‑rich, no‑debt position combined with an 80% EBITDA→FCF conversion target provides lasting financial flexibility to fund organic growth, invest in technology, and pursue acquisitions without overleveraging. This structural strength reduces refinancing risk and supports durable execution of strategy.
M&A Momentum & IntegrationSuccessful early integration of Evolent assets and a large business‑development pipeline create durable optionality to expand geographic density, cross‑sell platform services, and capture scale economics. Efficient integration improves unit economics and accelerates long‑term margin expansion.
Bears Say
Thin Profit MarginsDespite a multi‑year turnaround, margins are still low and TTM margins have softened versus prior years, leaving earnings sensitive to payer reimbursement shifts, cost inflation, or slower practice adoption. Persistent thin margins constrain buffer for adverse shocks and limit reinvestment capacity.
Softening Cash Flow MomentumDeclining TTM free cash flow and a negative operating cash coverage ratio signal working‑capital or timing pressures that can persist across quarters. Weaker cash conversion could force tradeoffs between M&A, tech investment, or dividend/return policies and reduces the margin for execution risk.
Payer / Policy UncertaintyEvolving CMS rules (V28) and Medicare Advantage dynamics create structural contracting uncertainty that can change risk/reward of capitation vs shared‑risk models. Management’s reluctance to take downside Medicaid/fully capitated risk may limit upside capture if market shifts favor full capitation, constraining long‑term margin potential.
Privia Health Group News
PRVA FAQ
What was Privia Health Group, Inc.’s price range in the past 12 months?
Privia Health Group, Inc. lowest stock price was $18.77 and its highest was $26.51 in the past 12 months.
What is Privia Health Group, Inc.’s market cap?
Privia Health Group, Inc.’s market cap is $3.22B.
When is Privia Health Group, Inc.’s upcoming earnings report date?
Privia Health Group, Inc.’s upcoming earnings report date is Aug 06, 2026 which is in 40 days.
How were Privia Health Group, Inc.’s earnings last quarter?
Privia Health Group, Inc. released its earnings results on May 07, 2026. The company reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.075 by -$0.055.
Is Privia Health Group, Inc. overvalued?
According to Wall Street analysts Privia Health Group, Inc.’s price is currently Undervalued.
Does Privia Health Group, Inc. pay dividends?
Privia Health Group, Inc. does not currently pay dividends.
What is Privia Health Group, Inc.’s EPS estimate?
Privia Health Group, Inc.’s EPS estimate is 0.07.
How many shares outstanding does Privia Health Group, Inc. have?
Privia Health Group, Inc. has 126,012,375 shares outstanding.
What happened to Privia Health Group, Inc.’s price movement after its last earnings report?
Privia Health Group, Inc. reported an EPS of $0.02 in its last earnings report, missing expectations of $0.075. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Privia Health Group, Inc.?
Currently, no hedge funds are holding shares in PRVA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Privia Health Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$30.60 (27.39% Upside)
$30.60 (27.39% Upside)
Blogger Sentiment
Bullish
PRVA Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 327.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $192.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 0.1%
Last 30 Days ▼ 0.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
12.78%
12-Months-Change
Fundamentals
Return on Equity
3.02%
Trailing 12-Months
Asset Growth
19.80%
Trailing 12-Months
Company Description
Privia Health Group, Inc.
Privia Health Group, Inc. functions as a national entity focused on empowering physicians throughout the United States. It partners with medical groups, health plans, and health systems, with the primary objective of optimizing physician practices, enhancing patient experiences, and appropriately compensating clinicians for care delivered both virtually and in person. To achieve this, Privia offers a comprehensive suite of services. These include technology and population health tools designed to streamline independent providers' workflows; a Management Services Organization (MSO) that alleviates administrative tasks, freeing providers to focus on clinical care; a single-TIN medical group, which bolsters payer negotiations, facilitates clinical integration, and aligns financial incentives; an Accountable Care Organization (ACO) designed to engage patients, reduce inefficient utilization, and improve care coordination and patient quality metrics, thereby advancing value-based care; and a network connecting providers with new patient populations and enabling custom contracts with purchasers and payers. Founded in 2007, the company's headquarters are located in Arlington, Virginia. Privia Health Group, Inc. was formerly a subsidiary of Brighton Health Group Holdings, LLC.
PRVA Company Deck
PRVA Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational momentum — double‑digit provider and attributed‑lives growth, healthy practice collections growth, significant adjusted EBITDA expansion, margin improvement, and successful early integration of Evolent — supported by a large M&A pipeline and clear technology/AI initiatives to drive future efficiency. Offsetting factors included management’s conservative approach to full‑year guidance (except attributed lives), quarter‑to‑quarter volatility from prior‑year adjustments and shared‑savings timing, Q1 seasonality of cash flows, and payer/policy uncertainties (e.g., MA/V28 dynamics and variability in capitated vs. shared‑risk economics). Overall, the positives on growth, profitability, balance sheet flexibility, and execution materially outweighed the cited risks and uncertainties.View all PRVA earnings summariesPRVA Stock 12 Month Forecast
Average Price Target
$30.60
▲(27.39% Upside)
Technical Analysis
Ownership Overview
0.90% Insiders
28.32% Mutual Funds
30.86% Other Institutional Investors
16.60% Public Companies and
Individual Investors